Our Portfolio of Companies
nContact, Inc. (formerly nContact Surgical, Inc.) - (Acquired by Atricure, Inc. - 2015)
nContact’s mission is to transform the underserved arrhythmia market through the advancement of less invasive, more efficacious ablation alternatives for cardiac arrhythmias. The Company’s lead technology, EPi-Sense™ Coagulation System with VisiTrax®, has CE Mark approval in Europe for the coagulation of cardiac tissue in the treatment of atrial fibrillation and atrial flutter. The EPi-Sense Coagulation System with VisiTrax is indicated for endoscopic coagulation of cardiac tissue in the U.S. nContact was founded in 2005 and is headquartered in Morrisville, North Carolina, USA.
Cayenne Medical, Inc. - (Acquired by Zimmer-Biomet - 2016)
Based in Scottsdale, Arizona, Cayenne Medical is a privately held medical device company defining new technology for the soft tissue reconstruction segment of the sports medicine market. The company was founded in 2005 and is focused on leading the transformation of traditional arthroscopic procedures, by applying advanced technology through minimally invasive techniques.
Visit the Cayenne Medical website
ExTensia (Sunnyvale, CA) is developing minimally invasive device technologies to treat congestive heart failure. The Extensia technologies use proprietary approaches to improve the function of the dilated heart by restoring key anatomic relationships and geometry.